Kuang Y

ORCID: 0000-0002-6830-0865 · 63 papers in corpus
2020
BMJ open ·doi:10.1136/bmjopen-2020-038153

IntroductionWomen with polycystic ovary syndrome (PCOS) undergoing in vitro fertilization (IVF) protocols are typically characterised by an increased number of oocytes retrieved. The oocytes are often of poor quality, leading to lower pregn…

2020
Frontiers in endocrinology ·doi:10.3389/fendo.2020.546232

ObjectiveTo evaluate whether endometrial thickness (EMT) change in response to progesterone has an effect on pregnancy outcomes in frozen-thawed embryo transfer (FET) cycles.DesignRetrospective observational study.SettingTertiary-care acade…

article 2020
Reproductive BioMedicine Online ·doi:10.1016/j.rbmo.2020.01.010

Research questionDoes preconception body mass index (BMI) affect neonatal outcomes in women with endometriosis who conceive with IVF?DesignThis retrospective study included 7086 women who delivered a singleton live birth through IVF between…

article 2020
Frontiers in endocrinology ·doi:10.3389/fendo.2020.00129

Methods: 450 infertile patients with severe endometriosis undergoing IVF/ICSI were randomized to: medroxyprogesterone acetate +hMG; dydrogesterone+hMG; and progesterone +hMG. Ovulation was induced with a gonadotropin-releasing hormone agoni…

article 2020
Annals of translational medicine ·doi:10.21037/atm.2020.02.15

BACKGROUND: This study investigated the effects of medroxyprogesterone acetate (MPA) on the oocytes and embryos in patients with advanced endometriosis who had a normal ovarian reserve and tubal infertility and received controlled ovarian h…

article 2020
Drug design, development and therapy ·doi:10.2147/dddt.s263138

PURPOSE: In patients who had advanced endometriosis, we use different protocols including GnRH agonist, GnRH antagonist and progestin-primed ovarian stimulation (PPOS) protocols to assess live-birth congenital malformations delivered after …

2020
Frontiers in physiology ·doi:10.3389/fphys.2020.00415

BackgroundPrevious studies have reported the association between embryo quality and perinatal outcomes in fresh cycles, after cleavage-stage or blastocyst embryo transfer, and found no significant difference. However, in terms of vitrified-…

2020
Annals of translational medicine ·doi:10.21037/atm-20-1459

BackgroundPeak endometrial thickness (EMT), measured on the end of follicular phase or early luteal phase, is the most widely used marker for endometrial receptivity during infertility treatment. However, the clinical significance of follic…

2020
Archives of gynecology and obstetrics ·doi:10.1007/s00404-020-05568-5

PurposeTo explore the trends of oocyte and pregnancy outcomes over the ovulation trigger-OPU (oocyte pickup) time interval in four mainly used COH protocols.MethodsThis retrospective study was conducted between January 2013 and July 2018. T…

article 2020
Frontiers in endocrinology ·doi:10.3389/fendo.2020.00391

Purpose To screen out specific protein with different concentration in follicular fluid from advanced endometriosis and determine its direct effect on mouse oocytes matured in vitro. Methods Follicular fluid samples were obtained from 25 pa…

2019
Frontiers in endocrinology ·doi:10.3389/fendo.2019.00325

Background: The ability of anti-Müllerian hormone (AMH) to predict ovarian response has been studied extensively in gonadotropin-releasing hormone agonist and antagonist treatments, but no information is available regarding its value in pro…

article 2019
Frontiers in endocrinology ·doi:10.3389/fendo.2019.00763

Background: Endometriosis is one of the most challenging diseases for doctors helping infertile women conceive, which has become a common method to help maternal endometriosis-associated infertility. Women with advanced endometriosis posses…

2019
Frontiers in medicine ·doi:10.3389/fmed.2019.00316

The freeze-all strategy has been increasingly employed in the context of in vitro fertilization (IVF) cycles globally, but the relative advantages of this approach are not entirely understood. Herein we sought to assess how maternal age aff…

article 2019
Reproductive BioMedicine Online ·doi:10.1016/j.rbmo.2019.03.101

Research questionDoes the use of a levonorgestrel-releasing intrauterine system (LNG-IUS) improve the ongoing pregnancy rate of vitrified-warmed embryo transfer in women with adenomyosis undergoing IVF?DesignThis retrospective study include…

other 2019
Frontiers in endocrinology ·doi:10.3389/fendo.2019.00770

Background: Eutopic endometrium from women with endometriosis has functional changes in several aspects, which may largely account for the decrease in the quality of endometrial receptivity. It is of utmost importance to know whether freeze…

2019
Drug design, development and therapy ·doi:10.2147/dddt.s210228

PurposeDydrogesterone (DYG) has been demonstrated to be an alternative progestin in the progestin-primed ovarian stimulation (PPOS) protocol with comparable oocyte retrieval and pregnancy outcomes. However, its safety regarding neonatal out…

2019
Frontiers in endocrinology ·doi:10.3389/fendo.2019.00694

Background: To investigate the optimal ovulation trigger-oocyte pickup (OPU) interval of a progestin-primed ovarian stimulation (PPOS) protocol. Method: Patients with normal ovarian reserve in their first PPOS OPU cycle were enrolled in thi…

2019
Drug design, development and therapy ·doi:10.2147/dddt.s212235

ObjectiveFrozen-thawed embryo transfer enables surplus embryos derived from IVF or IVF-ICSI treatment to be stored and transferred in subsequent cycles into a more "physiologic environment". This study aimed to investigate the clinical effe…

2019
Drug design, development and therapy ·doi:10.2147/dddt.s230129

PurposeDydrogesterone (DYG) is an alternative progestin in progestin-primed ovarian stimulation (PPOS) protocol with weaker pituitary suppression than medroxyprogesterone acetate (MPA) in normal ovulatory women. However, the endocrinologica…

2019
Frontiers in endocrinology ·doi:10.3389/fendo.2019.00796

Objective: Progestin was recently used as an alternative of gonadotropin-releasing hormone (GnRH) analog for preventing premature luteinizing hormone (LH) surge with the aid of vitrification techniques, however, limited data were available …

2019
Annals of translational medicine ·doi:10.21037/atm.2019.11.74

BackgroundNon-elective freeze-all policy has been increasingly utilized in assisted reproductive treatment, but the optimal timing of frozen-thawed embryo transfer (FET) after controlled ovarian stimulation (COS) remains to be investigated.…

2018
Pharmaceutical biology ·doi:10.1080/13880209.2018.1492620

ContextScutellaria baicalensis Georgi (Lamiaceae) is a popular medicinal plant. Its roots are used as the famous traditional Chinese medicine Huang-Qin, which is recorded in Chinese Pharmacopoeia, European Pharmacopoeia, and British Pharmac…

2018
Journal of ovarian research ·doi:10.1186/s13048-018-0469-x

BackgroundPremature ovulation occurs at a high rate in natural-cycle in vitro fertilization (IVF), and cycle cancellation further hampers the overall efficiency of the procedure. While lower levels of estradiol (E2) are observed in preovula…

2018
Trials ·doi:10.1186/s13063-018-2850-x

BackgroundProgress in vitrification techniques has allowed reproductive physicians to consider new strategies for using progestin as an alternative to a GnRH analogue to improve in vitro fertilisation (IVF). However, the role of progestin i…

2018
Medical science monitor : international medical journal of experimental and clinical research ·doi:10.12659/msm.906602

BACKGROUND Increasing the success rate of in vitro fertilization/intracytoplasmic sperm injection (IVF/ICSI) is a duty of clinicians that has made many seek a variety of protocols. This study was undertaken to use a liquid chromatography-ma…